Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Hepperle

Jens Hepperle, Koln DE

Patent application numberDescriptionPublished
20090148501PROCESS FOR THE PREPARATION OF AROMATIZED CHEWING FOAMS FOR COSMETIC PRODUCTS - The invention relates to a process for the preparation of novel aromatized chewing foams for the oral care sector based on polyurethane-polyureas and aromatizing compositions06-11-2009
20110124773PROCESS FOR CONTINUOUSLY PRODUCING THERMOPLASTICALLY PROCESSABLE POLYURETHANES - The invention relates to a process for continuously producing thermoplastically processable polyurethanes with improved softening behaviour in a sequence of static mixers.05-26-2011

Jens Hepperle, Koeln DE

Patent application numberDescriptionPublished
20110215499EXTRUSION NOZZLE FOR POLYMERS - The invention relates to an improved die for the extrusion of melt strands of viscoelastic masses, and in particular to polymers and mixtures of polymers with other substances (such as solids, liquids or other polymers), where the use thereof avoids the formation of deposits in the region of the die.09-08-2011

Michael E. Hepperle, Kreuzlingen CH

Patent application numberDescriptionPublished
20100323953MACROCYCLIC HEPATITIS C PROTEASE INHIBITORS - The present invention provides novel macrocyclic compounds that mimic peptide substrates of the hepatitis C viral protease and inhibit the viral protease, more particularly as inhibitors of the NS3 serine protease from hepatitis C virus. Methods for synthesis of the compounds are also provided. The compounds find utility as antiviral agents directed at hepatitis C. The invention further provides methods of employing such inhibitors, alone or in combination with other therapeutic agents, to treat hepatitis C infection in a subject in need of such treatment.12-23-2010

Michael E. Hepperle, San Diego, CA US

Patent application numberDescriptionPublished
20090304631HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR - The invention provides compounds that inhibit a viral protease enzyme of the hepatitis C virus (HCV). The compounds are adapted for treatment of a HCV infection in a patient with the disease. The compounds include analogs of tripeptides and tetrapeptides that resemble the viral protease substrate. The invention also provides pharmaceutical compositions and combinations, methods of preparation of the compounds, and methods of treatment of patients afflicted with HCV using the compounds.12-10-2009
20090325889HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR - The present invention provides novel compounds which mimic peptides with a C-terminal penultimate proline, such compounds being useful as protease inhibitors, particularly as inhibitors of serine proteases, and more particularly as inhibitors of the NS3 serine protease from hepatitis C. The compounds find utility as antiviral agents directed at hepatitis C. The invention further provides methods of employing such inhibitors, alone or in combination with other therapeutic agents, to treat hepatitis C infection in a subject in need of such treatment.12-31-2009
20100093713BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE - This invention provides beta-carboline compounds of formula04-15-2010
20100120716MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR - Macrocyclic inhibitors of Hepatitis C protease are provided, the inhibitors including a boronic acid or ester group, a macrocyclic ring of about 13 to 25 atoms including at least two amide linkages, a proline-analogous group, and a connecting segment joining moieties on either side of the proline-analogous group. Methods of making the HCV protease-inhibitory compounds, methods of using the compounds, formulations of the compounds, and pharmaceutical combinations including the compounds, are provided.05-13-2010
20100311715ALPHA CARBOLINES AND USES THEREOF - This invention provides alpha-carboline compounds of formula I:12-09-2010

Patent applications by Michael E. Hepperle, San Diego, CA US